Children could benefit both directly and indirectly from vaccination. In light of the safety and
immunogenicity results from recent adult COVID-19 vaccine clinical trials, children should …

Vaccines are safe and effective in protecting individuals and populations against infectious
diseases. New vaccines are evaluated by a long-standing, rigorous, and transparent …

Tremendous efforts are undertaken to quickly develop COVID‐19 vaccines that protect
vulnerable individuals from severe disease and thereby limit the health and socioeconomic …

Methods PubMed, Embase, Cochrane Library, Clinicaltrial. gov, CNKI, Wanfang Data, China
Biomedical Literature Service System, and China Clinical Trial Registry were searched for …

As of July 2021, over 3 billion doses of a COVID-19 vaccines have been administered
globally, and there are now 19 COVID-19 vaccines approved for use in at least one country …

There is a strong consensus globally that a COVID-19 vaccine is likely the most effective
approach to sustainably controlling the COVID-19 pandemic. An unprecedented research …

Since the beginning in December 2019, the SARS-CoV-2 outbreak appeared to affect
mostly the adult population, sparing the vast majority of children who only showed mild …

Background As the epidemic progresses, universal vaccination against COVID-19 has been
the trend, but there are still some doubts about the efficacy and safety of COVID-19 vaccines …

As of October 2021, SARS-CoV-2 infections were reported among 512,613 children and
adolescents in Israel (~ 33% of all COVID-19 cases). The 5–11-year age group accounted …

The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a
vaccine to be available within 6 months. So who should be prioritized for vaccination when …